glp-1 agonist alzheimer's Potential Role of Glucagon-like Peptide-1 Receptor Agonists in the Treatment of Cognitive Decline and Dementia in Diabetes Mellitus Prevention of Dementia with GLP-1
Description
Findings from human islets and an in vivo T2D model suggest that these compounds may have the potential to improve T2D treatment
Soft, cold, or room-temperature options throughout for rough days
Sathyapalan (Eds.), Natural Products and Human Diseases
To connect with experts from Stony Brook Medicines Bariatric and Metabolic Weight Loss Center, visit our website or call (631) 444-2274.
